Suppr超能文献

外显子组测序在中国一个家系中鉴定出一种与常染色体显性非综合征性听力损失DFNA4B相关的新型癌胚抗原相关细胞黏附分子16(CEACAM16)突变。

Exome sequencing identifies a novel CEACAM16 mutation associated with autosomal dominant nonsyndromic hearing loss DFNA4B in a Chinese family.

作者信息

Wang Honghan, Wang Xinwei, He Chufeng, Li Haibo, Qing Jie, Grati Mhamed, Hu Zhengmao, Li Jiada, Hu Yiqiao, Xia Kun, Mei Lingyun, Wang Xingwei, Yu Jianjun, Chen Hongsheng, Jiang Lu, Liu Yalan, Men Meichao, Zhang Hailin, Guan Liping, Xiao Jingjing, Zhang Jianguo, Liu Xuezhong, Feng Yong

机构信息

Department of Otolaryngology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan, China.

Department of Head and Neck Surgery, Hunan Provincial Tumor Hospital and the Affiliated Tumor Hospital of Xiangya Medical School, Central South University, Changsha, Hunan, China.

出版信息

J Hum Genet. 2015 Mar;60(3):119-126. doi: 10.1038/jhg.2014.114. Epub 2015 Jan 15.

Abstract

Autosomal dominant nonsyndromic hearing loss (ADNSHL/DFNA) is a highly genetically heterogeneous disorder. Hitherto only about 30 ADNSHL-causing genes have been identified and many unknown genes remain to be discovered. In this research, genome-wide linkage analysis mapped the disease locus to a 4.3 Mb region on chromosome 19q13 in SY-026, a five-generation nonconsanguineous Chinese family affected by late-onset and progressive ADNSHL. This linkage region showed partial overlap with the previously reported DFNA4. Simultaneously, probands were analyzed using exome capture followed by next-generation sequencing. Encouragingly, a heterozygous missense mutation, c.505G>A (p.G169R) in exon 3 of the CEACAM16 gene (carcinoembryonic antigen-related cell adhesion molecule 16), was identified via this combined strategy. Sanger sequencing verified that the mutation co-segregated with hearing loss in the family and that it was not present in 200 unrelated control subjects with matched ancestry. This is the second report in the literature of a family with ADNSHL caused by CEACAM16 mutation. Immunofluorescence staining and western blots also prove CEACAM16 to be a secreted protein. Furthermore, our studies in transfected HEK293T cells show that the secretion efficacy of the mutant CEACAM16 is much lower than that of the wild type, suggesting a deleterious effect of the sequence variant.

摘要

常染色体显性非综合征性听力损失(ADNSHL/DFNA)是一种高度遗传异质性疾病。迄今为止,仅鉴定出约30个导致ADNSHL的基因,许多未知基因仍有待发现。在本研究中,全基因组连锁分析将疾病位点定位到SY-026这个五代非近亲中国家系的19号染色体q13上的一个4.3 Mb区域,该家系受迟发性和进行性ADNSHL影响。这个连锁区域与先前报道的DFNA4有部分重叠。同时,对先证者进行外显子捕获后接着进行二代测序分析。令人鼓舞的是,通过这种联合策略在癌胚抗原相关细胞黏附分子16(CEACAM16)基因的第3外显子中鉴定出一个杂合错义突变,即c.505G>A(p.G169R)。桑格测序证实该突变与家族中的听力损失共分离,并且在200名具有匹配血统的无关对照受试者中不存在。这是文献中关于由CEACAM16突变导致ADNSHL的家系的第二篇报道。免疫荧光染色和蛋白质印迹也证明CEACAM16是一种分泌蛋白。此外,我们在转染的HEK293T细胞中的研究表明,突变型CEACAM16的分泌效率远低于野生型,提示该序列变异具有有害作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb7b/4375019/018cf3bfd820/nihms-645127-f0001.jpg

相似文献

3
A novel missense variant in CEACAM16 gene causes autosomal dominant nonsyndromic hearing loss.
Ann Hum Genet. 2022 Jul;86(4):207-217. doi: 10.1111/ahg.12463. Epub 2022 Mar 16.
4
ELMOD3, a novel causative gene, associated with human autosomal dominant nonsyndromic and progressive hearing loss.
Hum Genet. 2018 Apr;137(4):329-342. doi: 10.1007/s00439-018-1885-0. Epub 2018 Apr 30.
7
Exome sequencing and linkage analysis identified tenascin-C (TNC) as a novel causative gene in nonsyndromic hearing loss.
PLoS One. 2013 Jul 30;8(7):e69549. doi: 10.1371/journal.pone.0069549. Print 2013.

引用本文的文献

1
Tectorial membrane: structure, function, and its implications for hearing loss.
Front Neurol. 2025 Aug 18;16:1630549. doi: 10.3389/fneur.2025.1630549. eCollection 2025.
3
Autosomal Dominant Non-Syndromic Hearing Loss (DFNA): A Comprehensive Narrative Review.
Biomedicines. 2023 Jun 1;11(6):1616. doi: 10.3390/biomedicines11061616.
4
A novel missense variant in CEACAM16 gene causes autosomal dominant nonsyndromic hearing loss.
Ann Hum Genet. 2022 Jul;86(4):207-217. doi: 10.1111/ahg.12463. Epub 2022 Mar 16.
5
Gene Family Mutations Associated With Inherited Breast Cancer Risk - A Comparative Oncology Approach to Discovery.
Front Genet. 2021 Aug 10;12:702889. doi: 10.3389/fgene.2021.702889. eCollection 2021.
6
[Identification of a novel mutation of CEACAM16 gene in a Chinese family with autosomal dominant nonsyndromic hearing loss].
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020 Sep;34(9):777-781. doi: 10.13201/j.issn.2096-7993.2020.09.003.
9
ELMOD3, a novel causative gene, associated with human autosomal dominant nonsyndromic and progressive hearing loss.
Hum Genet. 2018 Apr;137(4):329-342. doi: 10.1007/s00439-018-1885-0. Epub 2018 Apr 30.
10
Old gene, new phenotype: splice-altering variants in cause recessive non-syndromic hearing impairment.
J Med Genet. 2018 Aug;55(8):555-560. doi: 10.1136/jmedgenet-2018-105349. Epub 2018 Apr 27.

本文引用的文献

2
Clue to a new deafness gene: a large Chinese nonsyndromic hearing loss family linked to DFNA4.
J Genet Genomics. 2012 Dec 20;39(12):653-7. doi: 10.1016/j.jgg.2012.11.002. Epub 2012 Nov 16.
3
Extracellular IgC2 constant domains of CEACAMs mediate PI3K sensitivity during uptake of pathogens.
PLoS One. 2012;7(6):e39908. doi: 10.1371/journal.pone.0039908. Epub 2012 Jun 29.
6
Exome sequencing as a tool for Mendelian disease gene discovery.
Nat Rev Genet. 2011 Sep 27;12(11):745-55. doi: 10.1038/nrg3031.
7
A framework for variation discovery and genotyping using next-generation DNA sequencing data.
Nat Genet. 2011 May;43(5):491-8. doi: 10.1038/ng.806. Epub 2011 Apr 10.
8
Carcinoembryonic antigen-related cell adhesion molecule 16 interacts with alpha-tectorin and is mutated in autosomal dominant hearing loss (DFNA4).
Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4218-23. doi: 10.1073/pnas.1005842108. Epub 2011 Feb 22.
10
A method and server for predicting damaging missense mutations.
Nat Methods. 2010 Apr;7(4):248-9. doi: 10.1038/nmeth0410-248.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验